← Product Code [JJY](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJY) · K030089 # TRIAGE CARDIAC CONTROLS; TRIAGE CARDIO PROFILER CONTROLS (K030089) _Biosite Incorporated · JJY · Jan 23, 2003 · Clinical Chemistry · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJY/K030089 ## Device Facts - **Applicant:** Biosite Incorporated - **Product Code:** [JJY](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJY.md) - **Decision Date:** Jan 23, 2003 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 862.1660 - **Device Class:** Class 1 - **Review Panel:** Clinical Chemistry ## Indications for Use The Triage® Cardio ProfilER / Triage® Cardiac Controls are to be used with the Triage® Cardio ProfilER / Triage® Cardiac Panel and Triage® Meter to assist the laboratory in monitoring test performance. ## Device Story Triage® Cardio ProfilER / Triage® Cardiac Controls are quality control materials used to monitor the performance of Triage® diagnostic panels and meters in laboratory settings. The device serves as a reference standard to ensure test accuracy and reliability. It is a combination of two predicate control products, differing only in the use of an EDTA-based matrix compared to the heparin-based matrix of the predicate. The controls are utilized by laboratory staff to verify that the Triage® system is functioning correctly before or during patient sample analysis. ## Clinical Evidence No clinical data. Bench testing only. ## Technological Characteristics Quality control material (21 CFR 862.1660). Matrix contains EDTA. Designed for use with Triage® Meter and Cardiac Panel systems. ## Regulatory Identification A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls. ## Predicate Devices - Triage® Cardiac Controls ([K974461](/device/K974461.md)) - Triage® BNP Controls ([K000230](/device/K000230.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # 510(k) Summary of Safety and Effectiveness Triage® Cardio ProfilER / Triage® Cardiac Controls K030089 This 510(k) summary of safety and effectiveness is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. #### (To be determined) 510(k) Number: #### A. Name and Address of Submitter | Company Name: | Biosite Incorporated | |------------------------|---------------------------------------------| | Address: | 11030 Roselle Street
San Diego, CA 92121 | | Telephone: | (858) 455-4808 | | Fax: | (858) 535-8350 | | Contact Person: | Jeffrey R. Dahlen, Ph.D. | | Date Summary Prepared: | 1/7/03 | #### B. Device Names - 1. Trade Name Triage® Cardio ProfilER / Triage® Cardiac Controls - 2. Common / Usual Name Not Applicable 3. Classification Name Quality Control Material (Assayed and Unassaved) 21 CFR 862:1660 Class I Product Code: JJY #### C. Predicate Devices Triage® Cardiac Controls (K974461) Triage® BNP Controls (K000230) #### D. Device Description and Intended Use The Triage® Cardio ProfilER / Triage® Cardiac Controls are to be used with the Triage® Cardio ProfilER / Triage® Cardiac Panel and Triage® Meter to assist the laboratory in monitoring test performance. {1}------------------------------------------------ ## E. Summary of Comparison Data The Triage® Cardio ProfilER / Triage® Cardiac Controls are a combination of the two predicate devices. The only difference between the Triage® Cardio ProfilER / Triage® Cardiac Controls and the predicate devices is that the Triage® Cardio ProfilER / Triage® Cardiac Controls are prepared in a matrix that contains EDTA, while the Triage® Cardiac Controls are prepared in a matrix that contains heparin. # F. Conclusion The information provided in the premarket notification demonstrates that the Triage® Cardio ProfilER / Triage® Cardiac Controls are substantially equivalent to previously approved predicate devices. The information provided assures that the Triage® Cardio ProfilER / Triage® Cardiac Controls are safe and effective for their intended use. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The symbol is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. JAN 2 3 2003 Food and Drug Administration 2098 Gaither Road Rockville MD 20850 Jeffrey R. Dahlen, Ph.D. Principal Scientist Clinical and Regulatory Affairs Biosite Inc. 11030 Roselle Street San Diego, CA 92121 Re: k030089 > Trade/Device Name: Triage® Cardio ProfilER / Triage® Cardiac Controls Regulation Number: 21 CFR 862.1660 Regulation Name: Quality Control Material (Assayed and Unassayed). Regulatory Class: Class I Product Code: JJY Dated: January 7, 2003 Received: January 10, 2003 Dear Dr. Dahlen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If vour device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). {3}------------------------------------------------ Page 2 - This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 594-3084. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Steven Sutman Steven I. Gutman, M.D., M.B.A. Director Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Page 1 of 1 # K030089 510(k) Number (if known): (to be determined) Device Name: Triage® Cardio ProfilER / Triage® Cardiac Controls Indications For Use: The Triage® Cardio ProfilER / Triage® Cardiac Controls are to be used with the Triage® Cardio ProfilER / Triage® Cardiac Panel and Triage® Meter to assist the laboratory in monitoring test performance. # (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Jean Coogey Laporatory Devices 5 biky Number 2630089 Prescription Use✗ (Per 21 CFR 801.109) OR Over-The Counter Use (Optional Format 1-2-96) ر ز --- **Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJY/K030089](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJY/K030089) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com